Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.
PLoS One. 2013 Oct 23;8(10):e77232. doi: 10.1371/journal.pone.0077232. eCollection 2013.
PLoS One. 2013.
PMID: 24194875
Free PMC article.
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN.
Tahiri A, et al. Among authors: kleivi sahlberg k.
Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333. Epub 2013 Oct 8.
Carcinogenesis. 2014.
PMID: 24104550
Item in Clipboard
miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.
Ben-Elazar S, Aure MR, Jonsdottir K, Leivonen SK, Kristensen VN, Janssen EAM, Kleivi Sahlberg K, Lingjærde OC, Yakhini Z.
Ben-Elazar S, et al. Among authors: kleivi sahlberg k.
PLoS Comput Biol. 2021 Feb 10;17(2):e1008608. doi: 10.1371/journal.pcbi.1008608. eCollection 2021 Feb.
PLoS Comput Biol. 2021.
PMID: 33566819
Free PMC article.
Item in Clipboard
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.
Lindholm EM, Ragle Aure M, Haugen MH, Kleivi Sahlberg K, Kristensen VN, Nebdal D, Børresen-Dale AL, Lingjaerde OC, Engebraaten O.
Lindholm EM, et al. Among authors: kleivi sahlberg k.
Mol Oncol. 2019 Oct;13(10):2278-2296. doi: 10.1002/1878-0261.12561. Epub 2019 Aug 28.
Mol Oncol. 2019.
PMID: 31402562
Free PMC article.
Clinical Trial.
Item in Clipboard
A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Børresen-Dale AL, Santarpia L.
Kleivi Sahlberg K, et al.
Clin Cancer Res. 2015 Mar 1;21(5):1207-14. doi: 10.1158/1078-0432.CCR-14-2011. Epub 2014 Dec 29.
Clin Cancer Res. 2015.
PMID: 25547678
Item in Clipboard
Cite
Cite